Forest Baskett - Apr 11, 2022 Form 4 Insider Report for Trevi Therapeutics, Inc. (TRVI)

Role
10%+ Owner
Signature
/s/Louis Citron, attorney-in-fact
Stock symbol
TRVI
Transactions as of
Apr 11, 2022
Transactions value $
$4,999,998
Form type
4
Date filed
4/13/2022, 05:04 PM
Previous filing
Feb 1, 2022
Next filing
May 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRVI Common Stock Purchase $5M +2.63M +33.78% $1.90 10.4M Apr 11, 2022 See Note 2 F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired from the Issuer on April 11, 2022 pursuant to a Securities Purchase Agreement dated April 6, 2022.
F2 The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 16 securities in which the Reporting Person has no pecuniary interest.